University General Health System 2013 Revenue Increases 45%

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
University General Health System 2013 Revenue Increases 45% to $164 Million

HOUSTON, TX--(Marketwired - Jul 2, 2014) - University General Health System, Inc. (OTCQB: UGHS), a diversified, integrated multi-specialty health care delivery system, today announced its 2013 operating results, including a 44.8% improvement in total revenue, an improvement in average daily census of 52.9%, an increase in assets of $8.5 million, and a series of operational restructuring initiatives that have been designed to restore the Company's profitability in 2014. The Company will file its Form 10-K annual report with the SEC later today, in advance of an investor conference call that has been scheduled for Thursday, July 3, 2014 at 11:15 EDT to allow ample time for shareholders to review the SEC filing. Details on the conference call are provided later in this release.

FY2013 HIGHLIGHTS

  • Total revenue for 2013 increased $50.8 million, or 44.8%, to $164.0 million, compared with $113.2 million for the year ended December 31, 2012. The revenue increase was primarily attributable to a 52.9% increase in average daily census at the Company's hospitals. The average daily census for the year ended December 31, 2013 totaled 59, compared with an average daily census of 39 for the year ended December 31, 2012. In addition, the number of patient days increased 56.2% to 20,539, versus 13,151 patient days in the previous year. Adjusted patient days increased 36.0% to 35,435 in 2013, from 26,055 in 2012. Net patient service revenue increased 35% to $137.5 million in the year ended December 31, 2013, compared with $101.8 million in the year ended December 31, 2012. These increases were primarily driven by the acquisition of the Dallas hospital. The significant increase in net patient service revenue also benefited from hospital outpatient department (HOPD) acquisitions completed during 2013.
  • Hospital Segment revenue increased 44.3% to $148.3 million in 2013, compared with $102.8 million in 2012. The revenue increase was primarily attributable to a 51.3% increase in average daily census.
  • Net revenue in the Senior Living Segment increased 2.8% to approximately $8.1 million in 2013, versus approximately $7.9 million in 2012. This reflects an average revenue per unit occupied of $3,169 in 2013, compared with an average revenue per unit occupied of $3,096 in 2012. These are blended rates of assisted living-dominant facilities, which include independent living and memory care units. The senior living properties reported an overall average occupancy in excess of 92.9% in 2013, compared with 93.1% in 2012. This was higher than the senior living industry's national average occupancy of 89.7% for combined properties, as reported by the National Investment Center for the Seniors Housing (NIC) for the year 2013.
  • Support Services Revenue, net of intercompany revenue and management fees, totaled approximately $7.5 million in 2013, versus approximately $2.5 million in 2012. A net operating loss of approximately $1.6 million was recorded by the Support Services Segment in 2013, compared with a net operating loss of $0.1 million in the previous year. The 200% increase in revenue was due to an increase in the number of new clients, coupled with acquisitions completed in 2013.
  • Net patient revenue, before provision for doubtful accounts, from Medicare and Medicaid accounted for approximately 26.9% and 30.0% of total net patient revenue in 2013 and 2012, respectively. Revenue from managed care contracts and other third-party payors and self-pay (which was 1.6%) accounted for approximately 73.1% and 70.0% of net patient revenue in 2013 and 2012, respectively.
  • The provision for doubtful accounts rose to 16.1% at the end of 2013 from 8.1% at December 31, 2012, primarily due to a change in accounts receivable recognition. The Company expects this to normalize in 2014 to a more industry-consistent level, due to changes in accounts receivable (A/R) recognition and modifications within revenue cycle management, which will allow for easier auditing of revenues and Net A/R, and the implementation of better management tools.
  • Total assets increased 4.9% to $183.3 million as of December 31, 2013, compared with $174.8 million at December 31, 2012, due primarily to acquisitions in 2013.
  • Net days in accounts receivables improved to 56 as of December 31, 2013, versus 73 at December 31, 2012.
  • Shareholders' equity declined by $17.3 million, from $10.7 million on December 31, 2012 to a negative $6.6 million in December 31, 2013, primarily due to the acquisition of UGH-Dallas, along with several one-time expenses and write-downs that are identified below.
  • Adjusted EBITDA declined to ($4.4) million in 2013, versus $29.5 million in 2012. (Adjusted EBITDA is a non-GAAP measure that is reconciled with GAAP results in a table at the end of this press release).
  • An operating loss of approximately $17.1 million was recorded in 2013, versus operating income of approximately $19.1 million in the previous year, primarily due to the acquisition of UGH-Dallas and expenses related to certain marketing initiatives that are being discontinued.
  • The Company recorded a net loss attributable to common shareholders of ($35.7 million), or ($0.10) per share, in the most recent year, compared with a net loss attributable to common shareholders of ($4.0 million), or ($0.01) per share, in 2012,
  • A Summarization of Financial Performance by Business Segment (Adjusted EBITDA Summary - in $ millions):
       
       
Hospital Segment      
  UGH - Houston $ 19.7  
  UGH - Dallas $ (8.2 )
  ER Services $ (0.8 )
  Management Services $ (12.7 )
  Ancillary Services $ 1.2  
  Physician Services $ (0.8 )
  UGHS, Inc. $ (4.6 )
    Total $ (6.2 )
Senior Living:   1.6  
Support Services: $ (1.0 )
    Total Operating EBITDA $ (5.6 )
Other Non-Operating Adjustments $ 1.2  
    Total Adjusted EBITDA $ (4.4 )
           
           
  • Other Expense Items (in $ millions), many of which are non-recurring or have been eliminated for 2014 :
     
     
Medicare Recovery Adjustment $ 1.26
Self-Funded Health Claims $ 0.65
Siemens Lawsuit Accrual $ 2.10
Cost Report Adjustments $ 0.60
Application of A/R Methodology $ 5.50
Audit Fees $ 0.40
Marketing Initiatives $ 3.50
Management Services $ 2.67
Late Fees/Penalties $ 5.00
Preferred Shareholder Fees $ 0.94
  Total Other Expense Items $ 22.62
       
       

MANAGEMENT COMMENTS

"Our 45% increase in total revenue during 2013 was primarily attributable to an increase in the number of adjusted patient days and an increase in the number of surgeries performed," commented Dr. Hassan Chahadeh, M.D., Chairman and Chief Executive Officer of University General Health System, Inc. "We are very pleased to have recently achieved in-network status with United and Humana, two large third-party payors, and believe the value of these relationships will be reflected in our 2014 performance. The Company is confident that the effects of MNRP (Maximum Non-Network Reimbursement Plans) will continue to put downward pressure on out-of-network providers, and thus negotiations with major third-party payors will remain a high priority and necessary to the Company's future success. Nonetheless, we acknowledge that our greatest challenges in 2013 involved the amount of human and financial capital expended on our acquisition of the UGH-Dallas hospital and the slower-than-expected turnaround we have experienced at that facility. This has taken a significant toll on our financial performance, which we expect to improve in 2014."

"We have embarked upon a restructuring of our management team and refocused our priorities on organic growth within the system versus additional acquisitions, which have historically resulted in hospital outpatient department integration challenges," continued Chahadeh. "We have also focused on consolidation of our debt, to prepare for a more global refinancing in the future. The performance of our flagship Houston hospital remains stable, and the facility has recorded revenue increases while implementing a $1,000,000 reduction in monthly expenses from January to June 2014. As a Company, we have learned much from our rapid expansion and are determined to address the issues that resulted in a deterioration in our financial position during 2013."

OPERATIONAL RESTRUCTURING PLAN

"Our financial performance during 2013 reflected many challenges that we have addressed during the first half of 2014 and will continue to focus on throughout the balance of the year," added Chahadeh. "We have outlined below some of management's strategic restructuring accomplishments, most of which were implemented in the second quarter."

  • Dallas Hospital: Management has refocused its efforts on the core business of the hospital, while maintaining a successful gero-psych outpatient program and many of the existing hospital outpatient departments. Management believes the changes implemented will reduce the hospital's operating losses by over 50% in 2014. Management is also exploring opportunities for partnerships that can mitigate losses while continuing to provide all necessary services within the market.
  • All Hospital Outpatient Departments (HOPDs) have been evaluated relative to resource productivity, and those that are non-core or non-performing have been or will be eliminated or restructured.
  • Houston Hospital: Management has implemented cost containment measures that have already reduced expenses by over $1 million per month since January 2014. Revenue at UGH-Houston continued to increase during the first half of the current year.
  • Significant salary reductions have been implemented for all Executive Staff, and all of the previous non-cash executive compensation (9.6 million shares), which was subject to substantial risk of forfeiture, has been redeemed into treasury as of 12/31/2013. In addition the Company has implemented a reduction in force of all non-essential personnel.
  • The Company believes it has secured financing that addresses the growth in accounts payable and resolves outstanding payroll tax liabilities.
  • All non-core business segments are being examined to determine if dispositions would provide greater liquidity to the Company without a negative impact upon core hospital operations.
  • Management intends to refinance existing debt, while providing additional liquidity to support the anticipated turnaround in existing operations.
  • Ms. Kris Trent will be appointed Interim Chief Financial Officer, replacing Michael Griffin, who will continue to serve in business development. Ms. Trent will also oversee the treasury management function, while streamlining the Company's ability to file its required Securities and Exchange Commission quarterly and annual reports in a timely fashion. The Company also will be addressing treasury management as part of an overall restructuring of financial reporting systems. The accounting and information technology teams are working diligently to correct material weaknesses in revenue cycle management, while strengthening internal controls. The Company is hopeful that the Form 10-Qs for the first and second quarters will be filed in early August.

"These measures are significant and reflect our commitment to shareholders as we focus on improving University General's operating and financial performance in 2014," concluded Chahadeh.

Investor Conference Call

Management of University General Health System will host a conference call on Thursday, July 3, 2014 at 11:15 a.m. EDT. Shareholders and other interested parties may participate in tomorrow's conference call by dialing 877-374-8416 (international participants dial 412-317-6716) and requesting participation in the "University General Health System Conference Call" at least five minutes before 11:15 am EDT.

A replay of the conference call will be available one hour after the call through Thursday, July 10, 2014 at 9:00 a.m. EDT by dialing 877-344-7529 (international participants dial 412-317-0088) and entering the conference ID # 10048817.

NON-GAAP FINANCIAL MEASURES (ADJUSTED EBITDA)

Adjusted EBITDA is a measure of operating performance that is not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). Adjusted EBITDA should not be considered in isolation or as a substitute for net income (loss), income from operations or cash flows provided by or used in operations, as determined in accordance with GAAP. Adjusted EBITDA is a key measure of the Company's operating performance used by management to focus on operating performance and management without mixing in items of income and expense that relate to the financing and capitalization of the business. The Company defines Adjusted EBITDA as net income (loss) before provision (benefit) for income taxes, non-operating (income) expense items, (gain) loss on sale of assets, depreciation and amortization (including non-cash impairment charges), amortization of deferred gains, and non-cash stock-based compensation expense.

The Company believes Adjusted EBITDA is useful to investors in evaluating its performance, results of operations and financial position for the following reasons:

  • It is helpful in identifying trends in day-to-day performance because the items excluded have little or no significance to day-to-day operations;
  • It provides an assessment of controllable expenses and affords management the ability to make decisions that are expected to facilitate meeting current financial goals and achieve optimal financial performance; and
  • It is an indication of whether adjustments to current spending decisions are necessary.

ABOUT UNIVERSITY GENERAL HEALTH SYSTEM, INC.

University General Health System, Inc. ("University General") is a diversified, integrated multi-specialty health care provider that delivers physician-centric, high quality patient-oriented services by providing timely, innovative health solutions that are uniquely competitive, efficient, and adaptive in today's health care delivery environment. The Company currently operates two hospitals, multiple ambulatory surgical centers, a number of diagnostic imaging, physical therapy and sleep clinics, and a hyperbaric wound care center in the Houston and Dallas metropolitan areas. Also, University General owns three senior living facilities, manages six senior living facilities, and owns a Support Services company that provides revenue cycle and luxury facilities management services.

The Company is headquartered in Houston, Texas, and its common stock trades on the OTCQB under the symbol "UGHS".

FORWARD-LOOKING STATEMENTS

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company's periodic filings with the Securities and Exchange Commission.

(Financial Highlights Follow) 

             
             
University General Health System, Inc.  
Consolidated Balance Sheets  
             
             
    December 31,  
    2013     2012  
ASSETS                
Current Assets                
Cash and cash equivalents   $ 1,708,898     $ 1,188,230  
Accounts receivable, less allowance for doubtful accounts of $36,802,691 and $21,422,475     23,102,262       20,941,005  
Inventories     2,447,567       1,458,089  
Prepaid expenses and other assets     6,635,294       3,986,378  
Current deferred taxes     1,146,358       1,729,150  
  Total Current Assets     35,040,379       29,302,852  
                 
Long-Term Assets                
Property, equipment and leasehold improvements, net     98,883,912       96,965,889  
Intangible assets, net     4,499,653       5,919,000  
Deferred tax assets     -       659,405  
Goodwill     42,613,953       39,271,829  
Other non-current assets, net     2,227,366       2,721,587  
  Total Long-Term Assets     148,224,884       145,537,710  
                 
  Total Assets   $ 183,265,263     $ 174,840,562  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)                
Current Liabilities                
Accounts payable   $ 21,696,595     $ 9,699,411  
Payables to related parties     2,131,730       2,133,053  
Accrued expenses     21,280,028       11,938,589  
Payroll taxes payable     5,852,673       1,610,836  
Income tax payable     14,604,353       11,813,198  
Deferred revenue     400,126       238,846  
Notes payable, current portion     24,369,226       26,089,305  
Notes payable to related parties, current portion     1,165,873       1,853,380  
Capital lease obligations, current portion     859,862       826,800  
Derivative liability     516,650       4,897,053  
  Total Current Liabilities     92,877,116       71,100,471  
                 
Long-Term Liabilities                
Line of credit     20,072,926       12,579,933  
Notes payable, less current portion     41,654,523       46,947,860  
Deferred taxes     1,236,700       -  
Capital lease obligations, less current portion     31,069,580       30,928,491  
  Total Long-Term Liabilities     94,033,729       90,456,284  
                 
Total Liabilities     186,910,845       161,556,755  
                 
Commitments and contingencies                
                 
Series C, convertible preferred stock, $0.001 par value, 20,000,000 shares authorized, 3,396 and 3,379 shares issued and outstanding, respectively ($1,000 stated value)     2,971,221       2,566,308  
                 
Shareholders' Equity (Deficit)                
Preferred, par value $0.001, 20,000,000 shares authorized, Preferred stock Series B - 3,000 shares issued and outstanding      3        3  
Common stock, par value $0.001, 480,000,000 shares authorized, 377,223,630 and 343,459,294 shares issued and outstanding, respectively      371,224        343,459  
Additional paid-in-capital     83,916,725       65,419,774  
Shareholders' receivables     (2,539,667 )     (2,828,251 )
Accumulated deficit     (93,057,957 )     (57,186,915 )
  Total shareholders' equity (deficit)     (11,309,672 )     5,748,070  
Noncontrolling interest     4,692,869       4,969,429  
  Total equity (deficit)     (6,616,803 )     10,717,499  
  Total Liabilities and Shareholders' Equity (Deficit)   $ 183,265,263     $ 174,840,562  
                   
                   
             
             
University General Health System, Inc.  
Consolidated Statements of Income  
             
    Year Ended December 31,  
    2013     2012  
Revenues                
  Patient service revenues, net of contractual adjustments   $ 163,935,735     $ 112,184,538  
  Provision for doubtful accounts     (26,392,248 )     (10,384,706 )
  Net patient service revenue less provision for doubful accounts     137,543,487       101,799,832  
  Senior living revenues     7,922,924       7,712,750  
  Support services revenues     7,477,014       2,501,449  
  Other revenues     11,045,561       1,209,227  
    Total revenues     163,988,986       113,223,258  
                 
Operating expenses                
  Salaries, wages and benefits     77,569,460       39,627,334  
  Medical supplies     28,669,728       16,194,606  
  General and administrative expenses (includes related party expenses of $2,327,050 and $1,921,501, respectively)     63,379,990       32,766,205  
  Gain on extinguishment of liabilities     -       (3,644,068 )
  Depreciation and amortization (includes related party expenses of $0 and $685,162, respectively)     11,476,315       9,215,713  
    Total operating expenses     181,095,493       94,159,790  
Operating income (loss)     (17,106,507 )     19,063,468  
Other income (expense)                
Interest expense, net of interest income of $141,047 and $85,000 (includes related party interest expense $131,277 and $2,289,287)     (7,100,683 )     (6,111,582 )
Other income (expense)     1,591,711       (381,026 )
Direct investor expense     (4,918,121 )     (6,853,356 )
Change in fair market value of derivatives     (2,019,076 )     (4,937,170 )
Income (loss) before income tax     (29,552,676 )     780,334  
  Income tax expense     5,270,052       4,564,195  
Loss before noncontrolling interest     (34,822,728 )     (3,783,861 )
Net income attributable to noncontrolling interests     276,560       363,531  
Net loss attributable to the Company   $ (34,546,168 )   $ (3,420,330 )
                 
Less: Cash dividend-Convertible Preferred C Stock     (141,740 )     (46,921 )
Less: Accretion non-cash dividend-Convertible Preferred C Stock     (1,019,789 )     (512,190 )
                 
Net loss attributable to common shareholders   $ (35,707,697 )   $ (3,979,441 )
                 
Basic and diluted loss per share data:                
                 
  Basic loss per common share   $ (0.10 )   $ (0.01 )
                 
  Basic weighted average shares outstanding     358,688,151       311,995,342  
                 
  Diluted loss per common share   $ (0.10 )   $ (0.01 )
                 
  Diluted weighted average shares outstanding     358,688,151       311,995,342  
                   
                   
             
             
University General Health System, Inc.  
Consolidated Statements of Cash Flows  
             
    Year Ended December 31,  
    2013     2012  
Cash flows from operating activities:                
Net loss   $ (34,822,728 )   $ (3,783,861 )
Adjustments to reconcile net loss to net cash provided by operating activities:                
  Depreciation and amortization     11,476,315       9,215,713  
  Provision for doubtful accounts     26,392,248       10,384,706  
  Gain on sale of assets and other, net     1,700,411       (37,451 )
  Gain on extinguishment of liabilities     -       (3,644,068 )
  Deferred income tax expense (benefits)     2,478,897       (2,388,555 )
  Compensation expense     180,000       -  
  Warrants issuance costs     -       392,609  
  Direct investor expense     4,918,122       6,853,356  
  Change in fair market value of derivatives     2,019,076       4,937,170  
Net changes in operating assets and liabilities:                
  Accounts receivable     (28,553,505 )     (18,869,744 )
  Related party payables     (1,323 )     298,729  
  Inventories     (989,478 )     484,349  
  Prepaid expenses and other assets     (593,129 )     (2,108,971 )
  Accounts payable, accrued expenses and taxes payable     24,762,947       6,583,479  
  Deferred revenues     161,280       (76,030 )
    Net cash provided by operating activities     9,129,133       8,241,431  
Cash flows from investing activities:                
  Additions and acquisitions to property, equipment and leasehold improvements     (7,286,545 )     (5,850,056 )
  Business acquistions, net of cash acquired     (2,055,245 )     (2,180,203 )
  Investments in unconsolidated affiliates     (65,000 )     (249,493 )
    Net cash used in investing activities     (9,406,790 )     (8,279,752 )
Cash flows from financing activities:                
  Proceeds from revolving credit facility borrowings     113,993,564       39,253,933  
  Payments of revolving credit facility borrowings     (106,500,571 )     (26,674,000 )
  Distributions to noncontrolling interests     -       (172,762 )
  Issuance of common stock     2,200,000       5,403,832  
  Issuance of preferred stock     2,974,181       3,794,669  
  Dividend paid on Preferred C Convertible Stock     (163,345 )     (158,444 )
  Borrowings under notes payable     5,245,341       12,890,617  
  Payments on notes payable     (15,355,934 )     (16,945,280 )
  Payments on debt issuance costs     -       (1,511,251 )
  Borrowings under notes payable to related party     191,493       34,976  
  Payments on notes payable to related party     (879,000 )     (453,057 )
  Payments on capital leases     (907,404 )     (6,323,675 )
  Payments on line of credits     -       (8,451,025 )
    Net cash provided by financing activities     798,325       688,533  
                 
Net increase in cash and cash equivalents     520,668       650,212  
Cash and cash equivalents:                
  Beginning of period     1,188,230       538,018  
  End of period   $ 1,708,898     $ 1,188,230  
Supplemental disclosures of cash flow information:                
  Interest paid   $ 6,679,064     $ 6,194,924  
  Income taxes paid   $ -     $ 385,966  
Supplemental noncash investing activities:                
  Property and equipment additions financed   $ 1,081,555     $ 819,236  
Supplemental noncash financing activities:                
  Noncash consideration paid for acquisitions   $ 3,123,651     $ 37,164,490  
  Issuance of common stock   $ 1,794,903     $ 1,237,682  
  Transfer from related party and account payables to debt obligations   $ -     $ 2,510,836  
  Issuance on conversions of preferred stock   $ 2,892,735     $ 1,324,600  
  Derivative ceases to exist   $ 11,637,078     $ 7,702,031  
  Dividend on Preferred C Convertible Stock   $ 141,740     $ 46,921  
                   
                   
       
       
    Adjusted EBITDA 2013  
    Twelve Months Ended December 31,  
    2013     2012  
Net loss attributable to the Company   $ (34,546,168 )   $ (3,420,330 )
Income expense attributable to non-controlling interests     (276,560 )     (363,531 )
Provision (benefit) for income taxes     5,270,052       4,564,195  
Other non-operating expense (income)     (1,591,711 )     381,026  
Interest expense:                
  Debt and lease obligations     6,679,064       6,196,582  
Interest income     (141,047 )     (85,000 )
Direct investor expense     4,918,121       6,853,356  
Change in fair value of derivatives     2,019,076       4,937,170  
Depreciation and amortization     11,476,315       9,215,713  
Non-Cash Investor Transactions     1,794,903       1,237,682  
Adjusted EBITDA   $ (4,397,955 )   $ 29,516,863  
                 
                 

For Additional Information, Please Contact: Donald Sapaugh President (713) 375-7557 x 105 dsapaugh@ughs.net or R. Jerry Falkner, CFA RJ Falkner & Company, Inc. Investor Relations Counsel (830) 693-4400 info@rjfalkner.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 161

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 139

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 101

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 28

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 162

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading

Top 5 Most Recently Viewed Articles

Latham Group's Stock Target Rises: A Positive Outlook Ahead

Updated Category News Views 101

Stifel Holds a Positive View on Latham Group Inc. Stifel has recently reaffirmed its Buy rating for Latham Group Inc. (NASDAQ:SWIM) and bumped its price target to $7.00, up from the previous $6.80. This decision is fueled by upcoming investor meetings led by Latham Group's CEO, Scott Rajeski, and CFO, Oliver Gloe. These meetings aim to provide crucial insights into the...

Continue Reading
Keeper Delivers Undeniable Improvements in Account Management

Updated Category News Views 135

Keeper Introduces Instant Account Switching and Passkey Enhancements Keeper Security has recently unveiled a significant upgrade to its mobile applications and browser extension. This update is set to enhance user experience by introducing instant account switching and vital passkey features that make accessing different accounts faster than ever. Seamless Account...

Continue Reading
Sagard Real Estate Ventures into Growth with New Fund

Updated Category News Views 311

Sagard Real Estate Expands Portfolio with New Acquisition Sagard Real Estate, the firm formerly known as EverWest Real Estate Investors, is making waves in the real estate market with its recent acquisition of Vista Imperio. This strategic investment involves a 158-unit suburban garden-style multifamily property, marking a significant step forward for the company in its...

Continue Reading
Celebrating a Decade of Leadership in Complexity and Execution

Updated Category News Views 160

Reflecting on 10 Years of Team of Teams A decade ago, the revolutionary ideas presented in General Stanley McChrystal’s book, Team of Teams: New Rules of Engagement for a Complex World, emerged as a guiding light for leaders navigating complex environments. The principles outlined in this book have proven to be increasingly vital in today’s fast-paced world. Team of...

Continue Reading
Hakeem's Nomination Showcase for FinTech Excellence in 2024

Updated Category News Views 65

Hakeem Earns Recognition at the Singapore FinTech Festival Walee Group is thrilled to announce that its innovative product, Hakeem, has been nominated for the prestigious Singapore FinTech Festival - FinTech Excellence Awards. This accolade highlights the commitment of Walee Financial Services in developing solutions that enhance financial accessibility, particularly for...

Continue Reading